Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy

E. Haan, E.E. Moret, J.P.A. Wagenaar-Hilbers, R.M.J. Liskamp, M.H.M. Wauben

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)365-373
Number of pages9
JournalMolecular Immunology
Volume42
Issue number3
Publication statusPublished - 2005

Keywords

  • Farmacie(FARM)
  • Diergeneeskunde (DGNK)

Cite this